SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-005169
Filing Date
2021-03-02
Accepted
2021-03-02 08:00:16
Documents
14
Period of Report
2021-03-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36114
2 ex99-1.htm EX-99.1 73894
3 ex99-1_001.jpg GRAPHIC 11313
  Complete submission text file 0001493152-21-005169.txt   311758

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vbiv-20210302.xsd EX-101.SCH 3196
5 XBRL LABEL FILE vbiv-20210302_lab.xml EX-101.LAB 34592
6 XBRL PRESENTATION FILE vbiv-20210302_pre.xml EX-101.PRE 22717
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3599
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 21701326
SIC: 2834 Pharmaceutical Preparations